Mast cells also participate in AS progression; in particular, in addition to the increase in number in CAVS compared to that of nonpathological conditions [104], when activated, mast cell production of cathepsin G leads to adverse valve remodeling and elastin fragmentation [105]. This evidence concerns the gene ELN and aortic valve stenosis.